Doximity, Inc. $DOCS Shares Sold by Edmond DE Rothschild Holding S.A.

Key Points

• Edmond DE Rothschild Holding S.A. has significantly reduced its stake in Doximity, decreasing its position by 50.8% in the first quarter, now holding 273,325 shares valued at approximately $15.86 million.
• Major brokerages, including KeyCorp and Piper Sandler, have increased their price targets for Doximity to between $69.00 and $75.00, indicating a positive outlook.
• Insider selling has been notable, with directors unloading 32,000 shares worth about $1.93 million in the last 90 days, suggesting caution among company insiders.

Edmond DE Rothschild Holding S.A. lessened its position in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 50.8% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 273,325 shares of the company's stock after selling 281,840 shares during the period. Edmond DE Rothschild Holding S.A. owned approximately 0.15% of Doximity worth $15,861,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. VSM Wealth Advisory LLC acquired a new stake in shares of Doximity in the first quarter worth $29,000. Allworth Financial LP boosted its holdings in Doximity by 104.0% during the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI bought a new position in shares of Doximity in the first quarter valued at approximately $33,000. Spire Wealth Management raised its stake in shares of Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after acquiring an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group raised its position in Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after purchasing an additional 309 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Evercore ISI upgraded shares of Doximity from an "in-line" rating to an "outperform" rating and increased their price objective for the stock from $50.00 to $70.00 in a research note on Wednesday, July 9th. Piper Sandler raised their target price on shares of Doximity from $65.00 to $69.00 and gave the company an "overweight" rating in a research report on Monday, August 11th. Canaccord Genuity Group boosted their price objective on shares of Doximity from $50.00 to $59.00 and gave the stock a "hold" rating in a research note on Friday, August 8th. KeyCorp upped their price target on shares of Doximity from $65.00 to $70.00 and gave the company an "overweight" rating in a research report on Monday, July 14th. Finally, The Goldman Sachs Group set a $50.00 price target on shares of Doximity and gave the company a "neutral" rating in a research report on Wednesday, May 21st. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $66.21.

Insider Buying and Selling at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction that occurred on Friday, August 1st. The stock was sold at an average price of $57.09, for a total value of $114,180.00. Following the sale, the director owned 16,618 shares of the company's stock, valued at $948,721.62. The trade was a 10.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Regina M. Benjamin sold 5,000 shares of Doximity stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $63.00, for a total value of $315,000.00. Following the completion of the transaction, the director owned 16,618 shares of the company's stock, valued at $1,046,934. The trade was a 23.13% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 32,000 shares of company stock valued at $1,929,380 over the last quarter. 31.30% of the stock is owned by company insiders.

Doximity Price Performance

NASDAQ DOCS traded up $0.18 during mid-day trading on Tuesday, hitting $69.70. The stock had a trading volume of 378,326 shares, compared to its average volume of 2,237,524. The firm's 50 day moving average is $62.83 and its 200 day moving average is $59.81. Doximity, Inc. has a twelve month low of $36.12 and a twelve month high of $85.21. The stock has a market capitalization of $13.05 billion, a price-to-earnings ratio of 69.59, a PEG ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The company's quarterly revenue was up 15.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.28 EPS. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.